Public Employees Retirement Association of Colorado continued to hold its position in shares of Chemed Corp. (NYSE:CHE) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 3,205 shares of the company’s stock at the end of the second quarter. Public Employees Retirement Association of Colorado’s holdings in Chemed Corp. were worth $656,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in CHE. Capital Insight Partners LLC increased its position in shares of Chemed Corp. by 0.4% in the first quarter. Capital Insight Partners LLC now owns 7,074 shares of the company’s stock valued at $1,292,000 after buying an additional 30 shares in the last quarter. BNP Paribas Arbitrage SA increased its position in shares of Chemed Corp. by 1.0% in the first quarter. BNP Paribas Arbitrage SA now owns 3,891 shares of the company’s stock valued at $711,000 after buying an additional 39 shares in the last quarter. Municipal Employees Retirement System of Michigan increased its position in shares of Chemed Corp. by 1.1% in the first quarter. Municipal Employees Retirement System of Michigan now owns 3,700 shares of the company’s stock valued at $676,000 after buying an additional 40 shares in the last quarter. Capstone Asset Management Co. increased its position in shares of Chemed Corp. by 2.7% in the second quarter. Capstone Asset Management Co. now owns 1,857 shares of the company’s stock valued at $380,000 after buying an additional 49 shares in the last quarter. Finally, State of Alaska Department of Revenue increased its position in shares of Chemed Corp. by 2.8% in the first quarter. State of Alaska Department of Revenue now owns 1,810 shares of the company’s stock valued at $330,000 after buying an additional 50 shares in the last quarter. 97.78% of the stock is owned by hedge funds and other institutional investors.
Chemed Corp. (NYSE:CHE) opened at 187.59 on Friday. Chemed Corp. has a 52 week low of $130.05 and a 52 week high of $216.01. The company has a market capitalization of $3.00 billion, a P/E ratio of 46.54 and a beta of 1.14. The firm has a 50 day moving average of $199.37 and a 200-day moving average of $192.75.
Chemed Corp. (NYSE:CHE) last posted its earnings results on Tuesday, July 25th. The company reported $2.15 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.26. The firm had revenue of $415.06 million during the quarter, compared to analysts’ expectations of $407.56 million. Chemed Corp. had a net margin of 4.16% and a return on equity of 26.18%. The business’s revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.80 earnings per share. On average, analysts forecast that Chemed Corp. will post $8.20 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 1st. Stockholders of record on Monday, August 14th will be issued a $0.28 dividend. The ex-dividend date of this dividend is Thursday, August 10th. This represents a $1.12 dividend on an annualized basis and a dividend yield of 0.60%. This is a boost from Chemed Corp.’s previous quarterly dividend of $0.26. Chemed Corp.’s dividend payout ratio is 28.07%.
COPYRIGHT VIOLATION WARNING: “Chemed Corp. (CHE) Stake Held by Public Employees Retirement Association of Colorado” was originally published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this news story on another publication, it was illegally copied and republished in violation of US & international copyright legislation. The correct version of this news story can be accessed at https://stocknewstimes.com/2017/08/20/chemed-corp-che-stake-held-by-public-employees-retirement-association-of-colorado.html.
Several brokerages recently issued reports on CHE. BidaskClub downgraded shares of Chemed Corp. from a “strong-buy” rating to a “buy” rating in a report on Thursday, June 22nd. Oppenheimer Holdings, Inc. lifted their price target on shares of Chemed Corp. from $200.00 to $220.00 and gave the company an “outperform” rating in a report on Thursday, July 27th. TheStreet downgraded shares of Chemed Corp. from a “b+” rating to a “c+” rating in a report on Tuesday, July 25th. Royal Bank Of Canada reissued a “hold” rating and set a $209.00 price target on shares of Chemed Corp. in a report on Monday, July 31st. Finally, Zacks Investment Research raised shares of Chemed Corp. from a “hold” rating to a “buy” rating and set a $226.00 price target for the company in a report on Friday, July 28th. Three investment analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of $218.33.
In other news, insider Kevin J. Mcnamara sold 15,000 shares of the stock in a transaction dated Friday, July 28th. The shares were sold at an average price of $201.16, for a total value of $3,017,400.00. Following the completion of the transaction, the insider now owns 173,801 shares of the company’s stock, valued at $34,961,809.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director George J. Walsh III bought 1,000 shares of the company’s stock in a transaction dated Monday, June 26th. The stock was bought at an average cost of $204.56 per share, with a total value of $204,560.00. Following the acquisition, the director now directly owns 7,908 shares of the company’s stock, valued at approximately $1,617,660.48. The disclosure for this purchase can be found here. 5.32% of the stock is currently owned by corporate insiders.
Chemed Corp. Company Profile
Chemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company’s VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers.
Receive News & Ratings for Chemed Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed Corp. and related companies with MarketBeat.com's FREE daily email newsletter.
